Related Experiment Video
Updated: Jun 15, 2026
Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
Improving Infant Hydrocephalus Outcomes in Uganda: A Longitudinal Prospective Study Protocol for Predicting
Taylor A Vadset1,2, Ajay Rajaram1,2,3, Chuan-Heng Hsiao1,2
1Division of Newborn Medicine, Boston Children's Hospital, Boston, MA 02115, USA.
Insights
Infant hydrocephalus treatment using endoscopic third ventriculostomy and choroid plexus cauterization (ETV/CPC) is effective. This study monitors cerebral physiology and neurodevelopment to improve long-term outcomes in infants.
Area of Science:
- Pediatric Neurosurgery
- Neurocritical Care
- Developmental Neuroscience
Background:
- Infant hydrocephalus is a significant global health issue, disproportionately affecting developing nations with limited neurosurgical resources.
- Endoscopic third ventriculostomy and choroid plexus cauterization (ETV/CPC) offers an effective alternative to ventriculoperitoneal shunts (VPS), requiring fewer resources and less intensive post-operative care.
- Current treatment success is often based on ventricle size, which shows limited correlation with treatment failure or long-term infant outcomes.
Purpose of the Study:
- To monitor hydrocephalus progression and treatment response in infants undergoing ETV/CPC.
- To investigate the relationship between cerebral physiological parameters, brain growth, and neurodevelopmental outcomes post-surgery.
- To establish a foundation for evidence-based guidelines in infant hydrocephalus management through physiological monitoring.
Main Methods:
- Enrollment of 300 infants treated for hydrocephalus at CURE Children's Hospital of Uganda (CCHU).
- Pre- and post-operative measurement of cerebral tissue oxygenation (SO2), cerebral blood flow (CBF), and cerebral metabolic rate of oxygen consumption (CMRO2) using frequency-domain near-infrared spectroscopy combined with diffuse correlation spectroscopy (FDNIRS-DCS).
- Brain imaging for volumetric analysis and neurodevelopmental assessments until two years of age.
Main Results:
- This section details the study protocol, clinical workflow, data management, and analysis plan for an international, multi-center trial.
- Actual results will be derived from the collected physiological, imaging, and neurodevelopmental data.
Conclusions:
- This study will provide crucial insights into the physiological underpinnings of hydrocephalus progression and treatment response in infants.
- Findings are expected to guide the development of improved, evidence-based neurosurgical care strategies for infant hydrocephalus, particularly in resource-limited settings.
- The integration of cerebral physiological monitoring aims to enhance long-term neurodevelopmental outcomes for affected infants.
Abstract:
Infant hydrocephalus poses a severe global health burden; 80% of cases occur in the developing world where patients have limited access to neurosurgical care. Surgical treatment combining endoscopic third ventriculostomy and choroid plexus cauterization (ETV/CPC), first practiced at CURE Children's Hospital of Uganda (CCHU), is as effective as standard ventriculoperitoneal shunt (VPS) placement while requiring fewer resources and less post-operative care. Although treatment focuses on controlling ventricle size, this has little association with treatment failure or long-term outcome. This study aims to monitor the progression of hydrocephalus and treatment response, and investigate the association between cerebral physiology, brain growth, and neurodevelopmental outcomes following surgery. We will enroll 300 infants admitted to CCHU for treatment. All patients will receive pre/post-operative measurements of cerebral tissue oxygenation (SO2), cerebral blood flow (CBF), and cerebral metabolic rate of oxygen consumption (CMRO2) using frequency-domain near-infrared combined with diffuse correlation spectroscopies (FDNIRS-DCS). Infants will also receive brain imaging, to monitor tissue/ventricle volume, and neurodevelopmental assessments until two years of age. This study will provide a foundation for implementing cerebral physiological monitoring to establish evidence-based guidelines for hydrocephalus treatment. This paper outlines the protocol, clinical workflow, data management, and analysis plan of this international, multi-center trial.
